Jerrold Bustos, MD
Anesthesiology · Azusa, CANPI 1942251384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $735 and has fallen 97.3% since, to $19 in 2025. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$649
- Boston Scientific$537
- Abbott$436
- Biodelivery Sciences International, Inc.$257
- Scilex Pharmaceuticals Inc.$163
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$136
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 45 | $649 |
| Boston Scientific | 34 | $537 |
| Abbott | 28 | $436 |
| Biodelivery Sciences International, Inc. | 15 | $257 |
| Scilex Pharmaceuticals Inc. | 8 | $163 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $136 |
| Sentynl Therapeutics, Inc. | 12 | $135 |
| Medtronic(2 entities) | 3 | $130 |
| Forte Bio-pharma LLC | 6 | $117 |
| Almatica Pharma LLC | 5 | $105 |
| GRT US Holding, Inc. | 4 | $101 |
| Zyla Life Sciences, Inc. | 5 | $83 |
| AbbVie(2 entities) | 5 | $82 |
| Redhill Biopharma Inc. | 5 | $81 |
| Nevro Corp. | 3 | $57 |
| Fidia Pharma USA Inc. | 2 | $50 |
| IBSA Pharma Inc. | 2 | $34 |
| Si-bone, Inc. | 2 | $31 |
| Avanos Medical | 1 | $24 |
| Bioventus LLC | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Nalu Medical, Inc. | 1 | $15 |
| Valinor Pharma, LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Vertos Medical, Inc. | 1 | $12 |
How this compares
$3,396 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 18 | $291 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Azusa
- Jack JengSouth San Francisco$1.3M
- Roger PhillipsChico$434K
- David DeyhimyLaguna Hills$344K
- Maxime CannessonLos Angeles$336K
- Alexander RoherSan Diego$282K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Amir ShbeebLong Beach$216K
- Lawrence ChuStanford$205K
- Hendrikus LemmensStanford$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.